SCHEMBL3056539

SCHEMBL3056539

CCCC[P+](CCCC)(CCCC)CCCC.O=P([O-])(OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.43
TERT O14746 1/20 0.43
UCHL3 P15374 1/20 0.43
MAPK14 Q16539 1/20 0.43
ACHE P22303 1/20 0.39
NAAA Q02083 2/20 0.37
DNM1 Q05193 2/20 0.35
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.32
FDPS P14324 1/20 0.32
MMP1 P03956 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MMP7 P09237 1/20 0.31
MMP12 P39900 1/20 0.31
ECE1 P42892 1/20 0.31
MMP13 P45452 1/20 0.31
GAA P10253 1/20 0.31
MMP2 P08253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3052282 0.95 AKT1 (0.46) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL3057529 0.94 AKT1 (0.48) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL3059510 0.90 ACHE (0.41) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL3072638 0.83 ACHE (0.43) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL3070641 0.79 ACHE (0.48) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL11608393 0.76 ACHE (0.48) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL11705645 0.76 ACHE (0.48) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL31474639 0.76 ACHE (0.48) AKT1TERTUCHL3MAPK14ACHE
Potassium Ion SCHEMBL28287967 0.76 ACHE (0.48) AKT1TERTUCHL3MAPK14ACHE
SCHEMBL228211 0.74 NAAA (0.51) NAAADNM1MMP1MMP7MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2540761-B1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2016-08-31 EP disclosed
US-8853346-B2 Curable resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-10-07 US disclosed
US-20130018168-A1 CURABLE RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2013-01-17 US disclosed
EP-2540761-A1 CURABLE RESIN COMPOSITION Mitsubishi Gas Chemical Company, Inc. (JP) 2013-01-02 EP disclosed
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2010-10-21 US disclosed
US-20090118442-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2009-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267980-A1 CURING ACCELERATOR FOR DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN, DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN COMPOSITION, AND DEEP-ULTRAVIOLET-TRANSMITTING EPOXY RESIN CURED PRODUCT ELL, RAD54L, RPP30 AKT1 2966/4885TERT 46/4885UCHL3 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.